We are live on
!
Find out more
GIP
Greatmark Investment Partners Portfolio holdings
AUM
$906M
1-Year Est. Return
16.08%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+16.08%
3 Year Est. Return
+61.99%
5 Year Est. Return
+81.88%
10 Year Est. Return
+373.56%
AUM
$405M
AUM Growth
+$39.7M
(+11%)
Cap. Flow
+$5.09M
Cap. Flow
% of AUM
1.26%
Top 10 Holdings %
Top 10 Hldgs %
40.88%
Holding
138
New
5
Increased
56
Reduced
36
Closed
5
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Occidental Petroleum
OXY
|
+$1.56M |
| 2 |
Kohl's
KSS
|
+$967K |
| 3 |
Wells Fargo
WFC
|
+$837K |
| 4 |
Robert Half
RHI
|
+$577K |
| 5 |
Elevance Health
ELV
|
+$410K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$683K |
| 2 |
Global Payments
GPN
|
+$645K |
| 3 |
Emerson Electric
EMR
|
+$537K |
| 4 |
Microsoft
MSFT
|
+$526K |
| 5 |
Apple
AAPL
|
+$428K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.4% |
| 2 | Financials | 18.19% |
| 3 | Healthcare | 14.6% |
| 4 | Industrials | 12.73% |
| 5 | Consumer Discretionary | 8.81% |
Similar funds
TLIC
SWM
SDWMA
SDJVC
HIGP
GCA
PSCM
BDP
Greatmark Investment Partners's Q4 2019 Portfolio in Review
As of Q4 2019, Greatmark Investment Partners held 138 positions worth $405M, up 11% from $365M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Greatmark Investment Partners's Q4 2019 filing shows 5 new, 56 increased, 36 reduced and 5 closed positions. Its largest new stake was Occidental Petroleum: 38,984 shares worth $1.61M. The largest sale was Gilead Sciences, an estimated $683K.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
- Greatmark Investment Partners's largest Q4 2019 buy was Occidental Petroleum: 38,984 shares worth $1.61M.
- Greatmark Investment Partners added most to Kohl's in Q4 2019, an estimated $967K increase.
- Greatmark Investment Partners's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $683K.
- Greatmark Investment Partners fully exited Celgene Corp in Q4 2019, selling an estimated $298K.
- Greatmark Investment Partners's ten largest holdings make up 41% of its $405M portfolio in Q4 2019.
- Greatmark Investment Partners opened 5 new positions and closed 5 in Q4 2019.
- Greatmark Investment Partners's portfolio value rose 11% quarter-over-quarter to $405M.
Based on Greatmark Investment Partners's 13F filing for Q4 2019, filed 31 Jan 2020.